Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties.
-
Molette J
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Routier J
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Abla N
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Besson D
Special Program for Research & Training in Tropical Diseases (TDR), World Health Organization , Avenue Appia 20, 1211 Geneva 27, Switzerland.
-
Bombrun A
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Brun R
Swiss Tropical and Public Health Institute, Socinstrasse. 57, 4051 Basel, Switzerland , and University of Basel, Petersplatz 1, 4003 Basel, Switzerland.
-
Burt H
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Georgi K
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Kaiser M
Swiss Tropical and Public Health Institute, Socinstrasse. 57, 4051 Basel, Switzerland , and University of Basel, Petersplatz 1, 4003 Basel, Switzerland.
-
Nwaka S
Special Program for Research & Training in Tropical Diseases (TDR), World Health Organization , Avenue Appia 20, 1211 Geneva 27, Switzerland.
-
Muzerelle M
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
-
Scheer A
Merck Serono, 9 chemin des mines, 1202 Geneva, Switzerland.
Show more…
Published in:
- ACS medicinal chemistry letters. - 2013
English
Recent observations on the emergence of artemisinin resistant parasites have highlighted the need for new antimalarial treatments. An HTS campaign led to the identification of the 1-(1-aminopropan-2-ol)carbazole analogues as potent hits against Plasmodium falciparum K1 strain. The SAR study and optimization of early ADME and physicochemical properties direct us to the selection of a late lead compound that shows good efficacy when orally administrated in the in vivo P. berghei mouse model.
-
Language
-
-
Open access status
-
green
-
Identifiers
-
-
Persistent URL
-
https://sonar.rero.ch/global/documents/114417
Statistics
Document views: 68
File downloads: